Index of reports
> Cases with Coagulopathy (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Eraxis (Anidulafungin) where reactions include coagulopathy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Eraxis side effects in male
Reported by a pharmacist from United States on 2012-02-03
Patient: male, weighing 113.0 kg (248.6 pounds)
Reactions: Coagulopathy, Hypofibrinogenaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Eraxis
Other drugs received by patient: Vancomycin; Hydromorphone HCL; Eraxis; Atorvastatin; Esomeprazole; Tobramycin; Aspirin; Ezetimibe; Diphenhydramine HCL; Insulin Lispro; Metoprolol; Ferrous Sulfate TAB; Zosyn; Acetaminophen
Possible Eraxis side effects in male
Reported by a pharmacist from United States on 2012-01-23
Patient: male, weighing 64.0 kg (140.8 pounds)
Reactions: Renal Failure, Heparin-Induced Thrombocytopenia, International Normalised Ratio Increased, Laboratory Test Interference, Coagulopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Eraxis
Other drugs received by patient: Chlorhexidine Gluconate; Vancomycin; Aspirin; Metronidazole; Ipratropium Bromide; Ciprofloxacin; Heparin; Albuterol; Zosyn
|